stockmarketproxy

/

COONasdaq SEC EDGAR

COOPER COMPANIES, INC.

Ophthalmic Goods·SAN RAMON, CA·FY end 10/31·CIK 711404

Overview Financials Compensation Governance Insiders Filings

Financials

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$4.1B	$3.9B	$3.6B	$3.3B	$2.9B
Gross Profit	$2.7B	$2.6B	$2.4B	$2.1B	$2.0B
Operating Income	$682.9M	$705.7M	$533.1M	$507.6M	$505.8M
Net Income	$374.9M	$392.3M	$294.2M	$385.8M	$2.9B
Operating CF	$796.1M	$709.3M	$607.5M	$692.4M	$738.6M
Capex	$362.4M	$421.2M	$392.5M	$242.0M	$214.4M
Free Cash Flow	$433.7M	$288.1M	$215.0M	$450.4M	$524.2M
Buybacks	$290.1M	$0	$0	$78.5M	$24.8M
Dividends	$0	$0	$3.0M	$3.0M	$1.5M

Gross Margin	65.5%	66.6%	65.6%	64.7%	66.9%
Operating Margin	16.7%	18.1%	14.8%	15.3%	17.3%
Net Margin	9.2%	10.1%	8.2%	11.7%	100.8%
FCF Margin	10.6%	7.4%	6.0%	13.6%	17.9%
R&D / Revenue	4.2%	4.0%	3.8%	3.3%	3.2%
Effective Tax	33.8%	32.6%	28.7%	18.8%	-499.1%
Debt / Equity	0.30	0.32	0.33	0.33	0.20
Buybacks / FCF	66.9%	0.0%	0.0%	17.4%	4.7%

Peer comparison

Ophthalmic Goods · 1 peer

CEO Pay Ratio

COO

331:1

BLCO

632:1

CEO total comp

COO

$16M

BLCO

—

Net Margin

COO

9.2%

BLCO

-7.1%